CHEMICAL BANK - BAXTER INTL INC ownership

BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,081 filers reported holding BAXTER INTL INC in Q1 2019. The put-call ratio across all filers is 0.67 and the average weighting 0.3%.

About BAXTER INTL INC

Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.

Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.

Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.

Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.

Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Quarter-by-quarter ownership
CHEMICAL BANK ownership history of BAXTER INTL INC
ValueSharesWeighting
Q2 2019$1,213,000
+3.1%
14,808
+2.4%
0.14%
+3.8%
Q1 2019$1,176,000
+25.1%
14,465
+1.3%
0.13%
+14.7%
Q4 2018$940,000
-27.6%
14,274
-15.2%
0.12%
-14.1%
Q3 2018$1,299,000
+4.4%
16,8420.0%0.14%
+0.7%
Q2 2018$1,244,000
+22.3%
16,842
+7.7%
0.13%
+20.7%
Q1 2018$1,017,000
+0.6%
15,6420.0%0.11%
+1.8%
Q4 2017$1,011,000
+34.1%
15,642
+30.2%
0.11%
+29.8%
Q3 2017$754,000
-31.0%
12,017
-33.4%
0.08%
-29.4%
Q2 2017$1,092,000
+16.5%
18,037
-0.2%
0.12%
+14.4%
Q1 2017$937,000
-2.7%
18,067
-16.8%
0.10%
-5.5%
Q4 2016$963,000
+83.4%
21,716
+97.1%
0.11%
+54.9%
Q3 2016$525,000
+4.4%
11,018
-0.9%
0.07%
+1.4%
Q2 2016$503,000
+4.6%
11,118
-5.1%
0.07%
+4.5%
Q1 2016$481,000
-1.4%
11,718
-8.4%
0.07%
-1.5%
Q4 2015$488,000
-3.4%
12,798
-16.8%
0.07%
-6.8%
Q3 2015$505,000
-53.4%
15,376
-0.8%
0.07%
-49.3%
Q2 2015$1,084,000
+4.9%
15,501
+2.8%
0.14%
+6.7%
Q1 2015$1,033,000
+1.9%
15,076
+9.0%
0.14%
+2.3%
Q4 2014$1,014,000
+9.1%
13,826
+6.7%
0.13%
-18.0%
Q3 2014$929,000
+1.8%
12,953
+2.6%
0.16%
+3.9%
Q2 2014$913,000
+9.3%
12,628
+11.3%
0.16%
+3.3%
Q1 2014$835,000
+23.3%
11,343
+16.4%
0.15%
+24.0%
Q4 2013$677,000
+6.3%
9,743
+0.5%
0.12%
-1.6%
Q3 2013$637,000
-5.2%
9,693
-0.1%
0.12%
-6.8%
Q2 2013$672,0009,7010.13%
Other shareholders
BAXTER INTL INC shareholders Q1 2019
NameSharesValueWeighting ↓
JONES ROAD CAPITAL MANAGEMENT, L.P. 200,000$7,548,0006.60%
BOONE CAPITAL MANAGEMENT LLC 469,405$17,715,3455.59%
Soditic Asset Management LLP 186,920$7,054,3615.43%
JONES ROAD CAPITAL MANAGEMENT, L.P. 131,000$4,943,9404.32%
Camber Capital Management LP 3,000,000$113,2203.73%
Carmignac Gestion 4,848,773$182,991,7183.36%
SHAPIRO CAPITAL MANAGEMENT LLC 3,028,799$114,306,8743.33%
Hillman Capital Management, Inc. 219,248$8,274,4203.19%
Cincinnati Specialty Underwriters Insurance CO 201,500$7,604,6102.90%
Callodine Capital Management, LP 265,000$10,001,1002.79%
View complete list of BAXTER INTL INC shareholders